Dear Researchers,

The library will operate on a duty schedule between 22 December 2025 and 4 January 2026. During this period, it will be possible to upload publications, but all other services will be suspended.

Thank you for your understanding.

Dinya Tamás

University of Debrecen Faculty of Dentistry

Department of Human Surgery and Operative Techniques

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2001-2025

2025

Balogh, B., Tornai, D., Csillag, A., Tornai, I., Vitális, Z., Kováts, P., Antal-Szalmás, P., Dinya, T., Laleman, W., Coenraad, M., Trebica, J., Papp, M., MICROB-PREDICT Consortium: Secretory IgA Is a Key Marker Among Gut Barrier Dysfunction-Related Immunoglobulins Predicting Outcomes in ACLF.
Liver Int. 45 (10), 1-12, (article identifier: 70350), 2025.

doi DEA Scopus

Journal metrics:

Q1 Hepatology (2024)

Tornai, D., Balogh, B., Csillag, A., Budai, A., Kiss, A., Antal-Szalmás, P., Méhes, G., Baráth, L., Tornai, T. I., Tornai, I., Vitális, Z., Sipeki, N., Dinya, T., Enyedi, A., Rosenberger, F. A., Laleman, W., Coenraad, M., Aguilar, F., Claria, J., Moreau, R., Trebica, J., Papp, M., ICROB-PREDICT & PREDICT study group of the EASL-CLIF consortium: Serum Villin-1 - A novel marker of gut barrier damage in acutely decompensated cirrhosis: a cohort study and validation.
Aliment. Pharmacol. Ther. [Epub ahead of print], 1-15, 2025.

doi DEA

Journal metrics:

D1 Gastroenterology (2024)

Q1 Hepatology (2024)

D1 Pharmacology (medical) (2024)

2024

Kóder, G., Dinya, T., Tóth, D., Damjanovich, L., Ágoston, L., Tanyi, M.: Rare case of succesfully operated idiopathic colonic varicosity.
Int. J. Surg. Case Rep. 123, 1-8, (article identifier: 110196), 2024.

doi DEA WoS Scopus

Journal metrics:

Q3 Surgery

2023

Szabó, L., Dajnoki, Z., Somogyi, O., Gáspár, K., Hendrik, Z., Szabó, I. L., Szöllősi, A. G., Dinya, T., Töröcsik, D., Kapitány, A., Szegedi, A.: Cytokine profile of the epidermis is region specific and may determine the characteristics of inflammation.
Exp. Dermatol. 32 (7), 1120-1131, 2023.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry

D1 Dermatology

Q2 Molecular Biology

2022

Kósa, C., Balog, K., Dinya, T., Tóth, D.: Az emlősebészet 100 éve.
Magyar Seb. 75 (1), 33-35, 2022.

doi DEA

2019

Jenei, A., Dajnoki, Z., Retzlerné Medgyesi, B., Gáspár, K., Béke, G., Kinyó, Á., Méhes, G., Hendrik, Z., Dinya, T., Töröcsik, D., Zouboulis, C. C., Prens, E. P., Bíró, T., Szegedi, A., Kapitány, A.: Apocrine Gland-Rich Skin Has a Non-Inflammatory IL-17-Related Immune Milieu, that Turns to Inflammatory IL-17-Mediated Disease in Hidradenitis Suppurativa.
J. Invest. Dermatol. 139 (4), 964-968, (article identifier: 0022), 2019.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry

Q1 Cell Biology

D1 Dermatology

Q1 Molecular Biology

Pető, K., Dinya, T., Németh, N.: Vérzések, vérzéscsillapítás, mechanikai módszerek, hő, kémiai-biológiai anyagok.
In: Módszertani kézikönyv skill képzésekhez. Szerk.: Dénes Tamás, Hamar Attila, Horváth Kitti, Kovács Rita, Maróti Péter, ÁEEK, Budapest, 247-252, 2019. ISBN: 9789639661486

DEA

2018

Dinya, T., Tornai, T. I., Vitális, Z., Tornai, I., Balogh, B., Tornai, D., Antal-Szalmás, P., Sümegi, A., Andrikovics, H., Bors, A., Tordai, A., Papp, M.: Functional polymorphisms of innate immunity receptors are not risk factors for the non-SBP type bacterial infections in cirrhosis.
Liver Int. 38 (7), 1242-1252, 2018.

doi DEA

Journal metrics:

Q1 Hepatology

2017

Jenei, A., Gáspár, K., Dajnoki, Z., Béke, G., Retzlerné Medgyesi, B., Kinyó, Á., Hendrik, Z., Dinya, T., Szegedi, A., Kapitány, A.: Immune status of healthy apocrine gland-rich skin regions and its alterations in Hidradenitis Suppurativa.
J. Invest. Dermatol. 137 (10S), S274, 2017.

DEA WoS

10.

Földi, I., Tornai, T. I., Tornai, D., Sipeki, N., Vitális, Z., Tornai, I., Dinya, T., Antal-Szalmás, P., Papp, M.: Lectin-complement pathway molecules are decreased in patients with cirrhosis and constitute the risk of bacterial infections.
Liver Int. 37 (7), 1023-1031, 2017.

doi DEA

Journal metrics:

Q1 Hepatology

2016

11.

Tornai, T. I., Vitális, Z., Sipeki, N., Dinya, T., Tornai, D., Antal-Szalmás, P., Karányi, Z., Tornai, I., Papp, M.: Macrophage activation marker, soluble CD163 is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection.
Liver Int. 36 (11), 1628-1638, 2016.

doi DEA

Journal metrics:

Q1 Hepatology

12.

Papp, M., Tornai, T. I., Vitális, Z., Tornai, I., Tornai, D., Dinya, T., Sümegi, A., Antal-Szalmás, P.: Presepsin teardown: pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis.
World J. Gastroenterol. 22 (41), 1-14, 2016.

DEA

Journal metrics:

Q1 Gastroenterology

Q1 Medicine (miscellaneous)

13.

Antal-Szalmás, P., Földi, I., Tornai, D., Tornai, T. I., Vitális, Z., Tornai, I., Dinya, T., Papp, M.: Serum levels of lectin complement pathway molecules do not determine the risk of bacterial infections in patients with cirrhosis.
Clin. Chem. Lab. Med. 54 (10), 162, 2016.

doi DEA

2015

14.

Tornai, T. I., Tornai, D., Dinya, T., Vitális, Z., Lakatos, P., Antal-Szalmás, P., Tornai, I., Papp, M.: Soluble CD163 (sCD163) is a marker of infection in patients with cirrhosis and acute decompensation and an independent predictor of the short-term mortality.
Gastroenterology. 148 (4_Suppl_1), S-1009, 2015.

DEA WoS

15.

Tornai, T. I., Tornai, D., Sipeki, N., Földi, I., Dinya, T., Vitális, Z., Antal-Szalmás, P., Tornai, I., Papp, M.: Soluble CD163 (SCD163) is a marker of infection in patients with cirrhosis and acute decompensation and an independent predictor of the short-term mortality.
J. Hepatol. 62 (Supplement), S368, 2015.

doi DEA

2012

16.

Kósa, C., Garami, Z., Dinya, T., Fülöp, B.: Az invazivitás prediktív faktorai hengerbiopsziával in situ ductalis carcinomának diagnosztizált emlődaganatokban.
Magyar Seb. 65 (4), 216-219, 2012.

doi DEA

Journal metrics:

Q4 Medicine (miscellaneous)

17.

Garami, Z., Hascsi, Z., Varga, J., Dinya, T., Tanyi, M., Garai, I., Damjanovich, L., Galuska, L.: The value of 18-FDG PET/CT in early-stage breast cancer compared to traditional diagnostic modalities with an emphasis on changes in disease stage designation and treatment plan.
EJSO. 38 (1), 31-37, 2012.

doi DEA

Journal metrics:

Q1 Medicine (miscellaneous)

Q1 Oncology

D1 Surgery

2011

18.

Lazányi, K., Molnár, P., Bugán, A., Kiss, C., Szántó, J., Gonda, A., Tóth, Z., Hernádi, Z., Hadijev, J., Remenyik, É., Damjanovich, L., Dinya, T., Flaskó, T., Bágyi, P., Szluha, K.: Az onkológusok érzelmei.
Magyar Onkol. 55 (3), 205-212, 2011.

DEA

Journal metrics:

Q3 Medicine (miscellaneous)

Q3 Oncology

19.

Vitális, Z., Altorjay, I., Tornai, I., Palatka, K., Kacska, S., Pályu, E., Tornai, D., Udvardy, M., Hársfalvi, J., Dinya, T., Veres, G., Lakatos, P., Papp, M.: Phenotypic polymorphism of haptoglobin: a novel risk factor for the development of infection in liver cirrhosis.
Hum. Immunol. 72 (4), 348-354, 2011.

doi DEA

Journal metrics:

Q2 Immunology

Q2 Immunology and Allergy

Q1 Medicine (miscellaneous)

2010

20.

Altorjay, I., Vitális, Z., Tornai, I., Palatka, K., Kacska, S., Farkas, G., Udvardy, M., Hársfalvi, J., Dinya, T., Orosz, P., Lombay, B., Pár, G., Pár, A., Csak, T., Osztovits, J., Szalay, F., Csepregi, A., Lakatos, P., Papp, M.: Mannose-binding lectin deficiency confers risk for bacterial infections in a large Hungarian cohort of patients with liver cirrhosis.
J. Hepatol. 53 (3), 484-491, 2010.

doi DEA

Journal metrics:

D1 Hepatology

21.

Papp, M., Lakatos, P., Hársfalvi, J., Farkas, G., Palatka, K., Udvardy, M., Molnár, T., Farkas, K., Nagy, F., Veres, G., Lakatos, L., Kovács, Á., Dinya, T., Kocsis, K. Á., Papp, J., Altorjay, I., The Hungarian IBD Study Group: Mannose-binding lectin level and deficiency is not associated with inflammatory bowel diseases, disease phenotype, serology profile, and NOD2/CARD15 genotype in a large Hungarian cohort.
Hum. Immunol. 71 (4), 407-413, 2010.

doi DEA

Journal metrics:

Q3 Immunology

Q2 Immunology and Allergy

Q1 Medicine (miscellaneous)

22.

Papp, M., Norman, G. L., Vitális, Z., Tornai, I., Altorjay, I., Földi, I., Udvardy, M., Shums, Z., Dinya, T., Orosz, P., Lombay, B., Pár, G., Pár, A., Veres, G., Csak, T., Osztovits, J., Szalay, F., Lakatos, P.: Presence of Anti-Microbial Antibodies in Liver Cirrhosis: a Tell-Tale Sign of Compromised Immunity?.
PloS One. 5 (9), e12957-1-e12957-9, 2010.

doi DEA

Journal metrics:

D1 Agricultural and Biological Sciences (miscellaneous)

D1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

D1 Medicine (miscellaneous)

2009

23.

Bartha, I., Dinya, T., Seres, I., Paragh, G., Ross, C., Hayden, M. R., Biró, S., Vargha, G.: Acute hypertriglyceridemic pancreatitis during pregnancy due to homozygous lipoprotein lipase gene mutation.
Clin. Chim. Acta. 400 (1-2), 137-138, 2009.

doi DEA

Journal metrics:

Q2 Biochemistry

Q1 Biochemistry (medical)

Q2 Clinical Biochemistry

Q1 Medicine (miscellaneous)

24.

Papp, M., Földi, I., Altorjay, I., Pályu, E., Udvardy, M., Tumpek, J., Sipka, S., Korponay-Szabó, I., Nemes, É., Veres, G., Dinya, T., Tordai, A., Andrikovics, H., Norman, G. L., Lakatos, P.: Anti-microbial antibodies in celiac disease: trick or treat?.
World J. Gastroenterol. 15 (31), 3891-3900, 2009.

doi DEA

Journal metrics:

Q2 Gastroenterology

Q1 Medicine (miscellaneous)

25.

Papp, M., Altorjay, I., Lakos, G., Tumpek, J., Sipka, S., Dinya, T., Palatka, K., Veres, G., Udvardy, M., Lakatos, P.: Evaluation of the Combined Application of Ethanol-Fixed and formaldehyde-fixed neutrophil substrates for identifying atypical perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease.
Clin. Vaccine Immunol. 16 (4), 464-470, 2009.

doi DEA

Journal metrics:

Q2 Clinical Biochemistry

Q2 Immunology

Q2 Immunology and Allergy

Q1 Medicine (miscellaneous)

Q2 Microbiology (medical)